BALM4BAUMER S.A.Company Data · 2T26updated 2026-08-24
1 Overview 4T10 — 2T26 · 63 quarters
BAUMER S.A.
BALM4Metalurgia e Siderurgia

Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally. The company offers orthopedic devices, such as conventional prosthesis, spine and neurosurgery, non-conventional prosthesis, trauma, and biomaterials; and hospital equipment, including CSSD, surgical center and ICU, and sterilization process monitoring. It also provides life science equipment comprising pharmaceutical production and research laboratory; bone regeneration consisting of structural, raw material, and specialties; and maintenance, sterilization process monitoring, rental, CME equipment management, technological update, and replacement parts, as well as inspection, qualification, and calibration services. In addition, the company offers the Baumer Academy platform for specialized courses in the areas of hospital equipment, bone regeneration, and orthopedic devices. Baumer S.A. was incorporated in 1952 and is headquartered in Pacaembu, Brazil.

SectorMetalurgia e Siderurgia
Company HeadquartersPacaembu, SP
Full Time Employees
CEOMr. Ruy Salvari Baumer
Listing SegmentBásico
Foundation1952
Customer Rating
Employee Rating
Estrutura Acionária
36%Free Float
Condustil Participações S/A26%
Ruy Salvari Baumer20%
Monica Salvari Baumer18%
Free Float36%
Valuation
PriceR$ 16,49
Shares Outstanding9.785
Market Capitalization161
( - ) Cash & Equivalents71
( + ) Total Debt28
( = ) Enterprise Value119
P/E6,3x
EV / EBITDA2,9x
R$ 16,49
Adj close · daily
▼ 1,6%
Income Statement
Revenue205
EBITDA41
EBIT35
Net Income25
SG&A %(46,0%)
Balance Sheet
Assets292
Cash71
Total Debt28
Net Debt(43)
Fixed Assets42
Working Capital67
Equity161
Invested Capital & Reinvestment
Invested Capital Turnover1,89x
Marginal IC Turnover14,03x
Reinvestment % NOPAT46,4%
Working Capital Turnover3,57x
Cash Conv. Cycle354,3
Fixed Assets Turnover4,96x
D&A % Fixed Assets14,9%
Capex % Revenue9,3%
25,6 %
RoIC · LTM
RoIC (LTM)
Margins & Returns
Revenue Growth(6,0%)
Gross Margin63,8%
EBITDA Margin20,1%
Net Income Margin12,4%
Effective Tax Rate21,0%
Operating Leverage3,81x
RoIC25,6%
RoE15,9%
Capital Structure
Current Ratio2,69x
Financial Leverage1,81x
Asset Turnover0,71x
Net Debt / EBITDA(1,04x)
Net Debt & Lease / EBITDA(1,04x)
Cash Flow
CFO Conversion101,5%
FCFF Yield16,0%
FCFE Yield15,4%
Payout Ratio204,4%
Dividend Yield27,6%
Interest % FCFF0,0%
Latest CVM filings
  • 2026-08-14reported 2T26
  • 2026-05-15reported 1T26
  • 2026-03-31reported 4T25
  • 2025-11-14reported 3T25
  • 2025-08-14reported 2T25
  • 2025-05-15reported 1T25